Cord Blood CD34+ (batch ≥2 million cells)
Cord Blood CD34+ (batch ≥2 million cells)
Cryopreserved ampule of Human Cord Blood CD34+ stem/progenitors. A batch contains ≥2 million cells. Entire batch needs to be purchased. Individual vials have 1 million cells each. Two or more vials are available per batch. The price is per vial.
This product is also available with HLA information if your research requires it:
≥1 million cells
≥ 2 million cells
If you don't need ≥2 million cells from the same donor, 1 million cells per donor is also available:
2C-101
Select Size
Product Overview
Lonza cord blood CD34+ cells (2C-101X) contain hematopoietic stem and progenitor cells, are isolated from cord blood mononuclear cells (MNCs) via positive immunomagnetic separation. They are ideal for studies relating to transplantation and stem cells and humanized mouse model development. The number of cells typically obtained from cord blood can be limiting and pose a challenge. Cord blood derived CD34+ (2C-101X) consists of ≥2 million cells hematopoietic stem cells from the same donor. Cells are ethically sourced and are isolated using Institutional Review Board (IRB) or other regulatory authority-approved consent forms and protocols. Large inventory supports stable supply from a single vendor.
Guarantee
Lonza guarantees the performance of Cells only if appropriate Lonza recommended Media and Reagents are used exclusively and the recommended storage and use protocols are followed. Any modifications made to the recommended cell systems including the use of alternative media, reagents or protocols, will void cell and media performance guarantees. If you need assistance in selecting the appropriate media, reagents, or protocol, please contact Lonza Scientific Support.
Request More InfoBenefits
More cells: Increase productivity with larger number of cells available from a single donor
High Purity Viability: Guaranteed to have a purity of ≥90% as indicated by CD34+ expression
High viability: They are guaranteed to contain ≥1 million viable cells per ampoule
Certificate of Analysis is provided for each cell lot purchased. HIV, HBV, HCV not detected
Supporting media: Use X-VIVO® 20 Medium for the expansion and differentiation.
Choices in CD34+ cell types: 2C-101 H and 2C-101 HX are available with HLA information. CD34+ cells derived from bone marrow (2M-101) and from adult mobilized blood (4Y-101D) are also available.
Applications
- Humanized mice models creation
- CAR-T therapy process development
- Regenerative medicine
- Autoimmune disease
- Transplantations studies
- Immunology
- Cancer research
SDS, CoA, and Instructions
Certificate of Analysis (CoA)
Please enter Lot Number, including all zeros, located on the product label and please take into account that it is case sensitive.
Educational Material
Brochures, White Papers etc.
-
Generation of hiPSCs from Cord Blood Cells With the 4D-Nucleofector® System
-
CD34+ Cells for Cell and Gene Therapy Process Development
In this interview Dr. Manon Destalminil, Bioprocessing Project Leader at CellProthera, discusses the advantages of using research-grade CD34+ cells for cell and gene therapy process development. Please register to read. -
Procedure for thawing Poietics™ cells